The multicentre collaborative OPTION study (where Prof Magnus Domellöf is a member of the national steering committee) has of the 28th November 2022 started up at Umeå University Hospital. Induction of labour (IOL) is currently performed at almost about 25% of all Swedish deliveries, for a number of different reasons, and the proportion of IOL […]
Read More
The N4 research group met for a workshop focusing on research relating to preterm infants, at a conference venue in Umeå on Friday 18 November 2022. The group consisted of pediatricians/neonatologists, PhD students, dietitians, a psychologist, a speech and language therapist, a senior research assistant and research nurses. The multidisciplinary approach provided for different inputs […]
Read More
Study to establish whether topically applied eye drops with dexamethasone reduces the need for laser treatment of retinopathy of prematurity (ROP) The aim is to investigate whether eye drops with dexamethasone can reduce the risk of ROP requiring laser treatment. Preliminary data suggest that this is the case, but this must now be confirmed in […]
Read More
The beginning of November saw two big news stories from the ESPGHAN Committee on Nutrition; firstly, the updated consensus-based conclusions and recommendations on nutrient intakes and nutritional management for preterm infants was published, with Magnus Domellöf as the last author. More information on these updated European guidelines published in the Journal of Pediatric Gastroenterology and […]
Read More
NorthPop machine learning/AI workshop 18 October 2022 A first NorthPop workshop on machine learning and artificial intelligence (AI) methods was held on Umeå University campus on Tuesday 18 October 2022. A group of 20 researches affiliated with the NorthPop study and invited experts from the Department of Mathematics and Mathematical Statistics and Umeå School of […]
Read More
European Academy of Paediatric Societies (EAPS) congress 7-11 October 2022, Barcelona The European Academy of Paediatric Societies (EAPS) congress was back as an in-person event and took place in Barcelona 7-11 October. The programme offered delegates talks from over 250 established professionals and the latest developments in paediatrics were presented over 200 sessions and 1200 […]
Read More
The N4 research group are starting up several new clinical trials in the autumn and winter of 2022. We plan to provide a brief introduction to each project over the coming months, and will start with ‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’, or GRANDIOSA. GRANDIOSA is a blinded, placebo-controlled, randomized clinical trial […]
Read More
We are happy to announce that over 7000 families are now part of the NorthPop study! We are also impressed by and grateful for the commitment shown by our participants during the corona pandemic, where interest in joining the study has remained high. Now over 20 000 individuals (mothers, partners and children) participate in this […]
Read More
The risk of developing asthma and eczema is higher in children treated with antibiotics in their first 18 months of life than in children who have not received antibiotics. This is shown by a study of roughly 1,300 families within the NorthPop cohort study. The study on antibiotic treatment and the risk of developing allergic […]
Read More
A big Thank You to everyone who participated in our NorthPop workshop yesterday Tuesday 7 June! This year we met again in person on Umeå University campus after two years of digital workshops during the pandemic. We listened to fantastic presentations showing the breadth of research within NorthPop, followed by interesting discussions in the afternoon. […]
Read More